Table 1.
Inverse variance weighted |
MR Egger |
Weighted median |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exposure | Outcome | F | R 2 | MR-PRESSO | b | SE | P | Q test p | b | SE | P | Q test p | b | SE | P |
| |||||||||||||||
RLS | PD | 217.558 | 0.035 | 0.832 | −0.003 | 0.031 | 0.916 | 0.780 | −0.019 | 0.064 | 0.767 | 0.729 | −0.020 | 0.043 | 0.632 |
PD | RLS | 191.791 | 0.0315 | 0.662 | −0.012 | 0.023 | 0.592 | 0.300 | −0.002 | 0.050 | 0.958 | 0.269 | −0.011 | 0.036 | 0.749 |
RLS, restless legs syndrome; PD, Parkinson’s disease; F, “strength” of the genetic instrumental variable; R2, proportion of variance in exposure variable explained by SNPs; MR-PRESSO, Mendelian Randomization Pleiotropy RESidual Sum and Outlier; MR, Mendelian randomization; b, beta; SE, standard error; Q, Cochran’s Q test.